148 related articles for article (PubMed ID: 3107811)
1. Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness.
Mira-y-Lopez R; Ossowski L
Cancer Res; 1987 Jul; 47(13):3558-64. PubMed ID: 3107811
[TBL] [Abstract][Full Text] [Related]
2. Modulation of plasminogen activator in rodent mammary tumors by hormones and other effectors.
Mira-y-Lopez R; Reich E; Ossowski L
Cancer Res; 1983 Nov; 43(11):5467-77. PubMed ID: 6684501
[TBL] [Abstract][Full Text] [Related]
3. Preservation of steroid hormone receptors in organ cultures of human breast carcinomas.
Mira-y-Lopez R; Ossowski L
Cancer Res; 1990 Jan; 50(1):78-83. PubMed ID: 2293560
[TBL] [Abstract][Full Text] [Related]
4. Three novel hormone-responsive cell lines derived from primary human breast carcinomas: functional characterization.
Vázquez SM; Mladovan A; Garbovesky C; Baldi A; Lüthy IA
J Cell Physiol; 2004 Jun; 199(3):460-9. PubMed ID: 15095293
[TBL] [Abstract][Full Text] [Related]
5. Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma.
Mira-y-Lopez R; Reich E; Stolfi RL; Martin DS; Ossowski L
Cancer Res; 1985 May; 45(5):2270-6. PubMed ID: 2985248
[TBL] [Abstract][Full Text] [Related]
6. [Estrogen dependent plasminogen activator in breast cancer cells; experimental and clinical studies].
Yamashita J; Inada K; Matsuo S; Kawano I; Misumi A; Akagi M
Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1932-8. PubMed ID: 2514343
[TBL] [Abstract][Full Text] [Related]
7. Relation between steroid receptor content and the response to hormone addition in isolated human breast cancer cells in short-term culture.
Israel N; Saez S
Cancer Res; 1978 Nov; 38(11 Pt 2):4314-7. PubMed ID: 698973
[TBL] [Abstract][Full Text] [Related]
8. Estradiol-dependent collagenolytic enzyme activity in long-term organ culture of human breast cancer.
Heuson JC; Pasteels JL; Legros N; Heuson-Stiennon J; Leclercq G
Cancer Res; 1975 Aug; 35(8):2039-48. PubMed ID: 167944
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
Busso N; Belin D; Failly-Crépin C; Vassalli JD
Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
[TBL] [Abstract][Full Text] [Related]
10. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7).
Butler WB; Kirkland WL; Gargala TL; Goran N; Kelsey WH; Berlinski PJ
Cancer Res; 1983 Apr; 43(4):1637-41. PubMed ID: 6682006
[TBL] [Abstract][Full Text] [Related]
11. Relationship of membrane-bound tissue type and urokinase type plasminogen activators in human breast cancers to estrogen and epidermal growth factor receptors.
Needham GK; Nicholson S; Angus B; Farndon JR; Harris AL
Cancer Res; 1988 Nov; 48(22):6603-7. PubMed ID: 3141047
[TBL] [Abstract][Full Text] [Related]
12. Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy.
Mira-y-Lopez R; Osborne MP; DePalo AJ; Ossowski L
Int J Cancer; 1991 Apr; 47(6):827-32. PubMed ID: 1901298
[TBL] [Abstract][Full Text] [Related]
13. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumor.
Geradts J; Richards J; Edery M; Pang K; Larson L; Nandi S
Cancer Res; 1986 Apr; 46(4 Pt 2):1920-7. PubMed ID: 3004710
[TBL] [Abstract][Full Text] [Related]
15. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
Butler WB; Kelsey WH; Goran N
Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
[TBL] [Abstract][Full Text] [Related]
16. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness.
Whitehead RH; Quirk SJ; Vitali AA; Funder JW; Sutherland RL; Murphy LC
J Natl Cancer Inst; 1984 Sep; 73(3):643-8. PubMed ID: 6381852
[TBL] [Abstract][Full Text] [Related]
17. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
18. [The concentration of tissue--type plasminogen activator (t-PA) in extracts of breast cancer tissue].
Ziółkowska E; Pietrusińska E; Łozyńska-Podhrebelna D
Pol Merkur Lekarski; 2008 Dec; 25(150):489-94. PubMed ID: 19205379
[TBL] [Abstract][Full Text] [Related]
19. Influence of tamoxifen and estradiol on the growth of human breast cancer cells in vitro.
Arafah BM; Griffin P; Gordon NH; Pearson OH
Cancer Res; 1986 Jul; 46(7):3268-72. PubMed ID: 3708561
[TBL] [Abstract][Full Text] [Related]
20. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Benz C; Hollander C; Miller B
Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
